Pembrolizumab reactivates pulmonary granulomatosis.

MLA

Al-dliw, Majdi, et al. “Pembrolizumab Reactivates Pulmonary Granulomatosis.” Respiratory Medicine Case Reports, vol. 22, July 2017, pp. 126–29. EBSCOhost, https://doi.org/10.1016/j.rmcr.2017.07.010.

APA

Al-dliw, M., Megri, M., Shahoub, I., Sahay, G., Limjoco, T. I., & Shweihat, Y. (2017). Pembrolizumab reactivates pulmonary granulomatosis. Respiratory Medicine Case Reports, 22, 126–129. https://doi.org/10.1016/j.rmcr.2017.07.010

Chicago

Al-dliw, Majdi, Mohammed Megri, Ibrahim Shahoub, Gaurav Sahay, Teresa I. Limjoco, and Yousef Shweihat. 2017. “Pembrolizumab Reactivates Pulmonary Granulomatosis.” Respiratory Medicine Case Reports 22 (July): 126–29. doi:10.1016/j.rmcr.2017.07.010.